Bioequivalence Study Of Verapamil

Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)

NCT05491330 ·Status: COMPLETED ·Phase: PHASE1

A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804

NCT01313793 ·Status: COMPLETED ·Phase: PHASE1

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

NCT00648622 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations

NCT07121868 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

NCT04729998 ·Status: UNKNOWN ·Phase: PHASE1

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

NCT06397144 ·Status: WITHDRAWN ·Phase: PHASE1

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

NCT01027689 ·Status: WITHDRAWN ·Phase: PHASE1

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

NCT00776113 ·Status: COMPLETED ·Phase: NA

Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions

NCT06600282 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

NCT00650416 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of Alprazolam Sublingual vs Oral Tablets

NCT00860119 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

NCT02263989 ·Status: COMPLETED ·Phase: PHASE1

A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

NCT02596100 ·Status: COMPLETED ·Phase: PHASE1

Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects

NCT00834873 ·Status: COMPLETED ·Phase: PHASE1

Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects

NCT01396577 ·Status: COMPLETED ·Phase: PHASE1

A Single Dose Bioequivalence Study Of Neratinib In Healthy Subjects

NCT01142063 ·Status: COMPLETED

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

NCT00775580 ·Status: COMPLETED ·Phase: NA

Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers

NCT02261129 ·Status: COMPLETED ·Phase: PHASE1

A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects

NCT02279485 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants

NCT06418607 ·Status: COMPLETED ·Phase: PHASE1

Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components

NCT00556920 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability Study With Enalapril in Healthy Volunteers

NCT02252692 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

NCT03071380 ·Status: COMPLETED ·Phase: PHASE1

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

NCT06248099 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects

NCT00834795 ·Status: COMPLETED ·Phase: PHASE1